Advancing Equitable COVID-19 Vaccination in Humanitarian Crisis
Health hera Health hera

Advancing Equitable COVID-19 Vaccination in Humanitarian Crisis

The World Health Organization (WHO), taking the lead in responding to this pressing issue, selected hera to conduct a study on the complexities of COVID-19 vaccine deployment and administration in humanitarian settings, with a specific focus on populations of concern (PoC). The study was initiated in March 2022 and concluded in March 2023, and encompassed case studies in multiple countries deeply affected by humanitarian crises: Cox's Bazar (Bangladesh), Colombia, the Democratic Republic of the Congo (DRC), Iraq, South Sudan, and Syria.

Read More
New partners, associates, and milestones
hera hera

New partners, associates, and milestones

We are delighted to announce that three new partners and one associate have joined hera. Each one brings unique expertise and energy, as well as commitment to our mission to work for the right to health and development for all.

Read More
Final assessment of the Third-Party Monitoring of the Lebanon Health Programme for Syrian Refugees and Vulnerable Lebanese Population
Health, Human rights hera Health, Human rights hera

Final assessment of the Third-Party Monitoring of the Lebanon Health Programme for Syrian Refugees and Vulnerable Lebanese Population

hera assessed an EU program offering healthcare to Syrian refugees and vulnerable Lebanese citizens in Lebanon. This program aimed to improve access to affordable and quality healthcare services. The evaluation, conducted despite challenges like political unrest and the COVID-19 pandemic, found the program successful.

Read More